rawfin.tv
GSK Unveils Three-Year Cost-Saving Plan to Boost R&D Investment
MarketsstocksAI Generated

GSK Unveils Three-Year Cost-Saving Plan to Boost R&D Investment

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

GSK has announced an ambitious three-year plan to implement cost-saving measures, aiming to redirect resources towards late-stage R&D programs. The pharmaceutical company also plans to relocate its research headquarters.

PharmaceuticalsR&DCost SavingsBiotechHealthcare

Related Articles

Ambarella Gains as Nvidia Emerges as Potential Third Bidder

Ambarella Gains as Nvidia Emerges as Potential Third Bidder

stocks
SpaceX and Tesla Boards Review Potential $3.5 Trillion Merger

SpaceX and Tesla Boards Review Potential $3.5 Trillion Merger

stocks
Elon Musk Explores Merger Between SpaceX and Tesla

Elon Musk Explores Merger Between SpaceX and Tesla

stocks
Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks